Resources
2015 ESC/ERS PH guidelines
PHA Europe
World Symposium on Pulmonary Hypertension (WSPH)
Opsumit®
Learn More About OPSUMIT®
Summary
A synopsis of the key benefits of OPSUMIT® in the treatment of PAH.
Studies
Details of the SERAPHIN study, where the safety and efficacy of OPSUMIT® were investigated in a Phase 3 study to assess the long-term benefits for pulmonary arterial hypertension (PAH) patients.
EM- 50402 -
